We further identified the YAP1-KLF5 oncogenic module was responsible for SRC-induced cancer stemness in TNBC cells, targeting YAP1-KLF5 module thus may represent a more precise therapeutic strategy for treating SRC activation-associated TNBC. This evidence concerns the gene SRC and cancer.